Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss Man was left nearly blind in his left eye from Ozempic side effects, after only a few months of using the popular diabetes and weight loss drug. July 10, 2025 Irvin Jackson Add Your Comments A lawsuit filed by a New York man alleges the makers of Ozempic knew, or should have known, that the side effects of the popular diabetes and weight loss drug could cause users to experience a rare eye condition, which results in sudden and incurable blindness, known as . According to the complaint (PDF) brought by Geoffrey Symonds in New Jersey federal court on July 2, defendant Novo Nordisk, and its U.S. subsidiaries, failed to warn consumers or the medical community that clinical trials, post-marketing studies and other evidence pointed to Ozempic being linked to a condition known as non-arteritic anterior ischemic optic neuropathy (NAION). NAION is caused by reduced blood flow to the optic nerve, resulting in sudden, painless vision loss, often in one eye. It is considered a medical emergency and can lead to permanent vision impairment. Ozempic (semaglutide) is approved to treat type 2 diabetes and belongs to a newer class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Since its approval in 2017, the drug’s weight loss benefits have led to the development of Wegovy, a version approved specifically to treat obesity. The medications, and competing GLP-1 drugs like Eli Lilly’s Mounjaro (tirzepatide) diabetes drug and its weight loss version, Zepbound, currently face thousands of gastroparesis lawsuits over gastrointestinal side effects that can cause stomach paralysis, as well as intestinal obstructions. Each claim includes similar allegations that the manufacturers downplayed adverse health risks they had likely been aware of before the drugs even hit the market. Ozempic Vision Loss Problems NAION Ozempic lawsuits first began to be investigated, and later filed, after Harvard researchers published a study in early July 2024, warning that patients using semaglutide may face a seven-fold increased risk of Ozempic NAION vision problems, such as sudden vision changes, blurred sight, blindness or other symptoms linked to the rare condition. These findings appeared to be confirmed by a study published in medRxiv in January, and European regulators issued a warning last month that the condition could affect as many as 1 in 10,000 Ozempic and Wegovy users. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Symonds’ lawsuit indicates that he used Ozempic from about November 2021 until about January 2022. In that short time, Symonds lost 85% of sight in his left eye. “As a result of using Ozempic, Plaintiff is suffering from vision loss bilaterally and dealing with anxiety due to his condition. Plaintiff is finding it hard to manage life due to his circumstances.” –Geoffrey Symonds v. Novo Nordisk et al The complaint notes that neither Symonds nor his physician were made aware of the risks of Ozempic NAION side effects, and continued to be unaware until the publication of the July 2024 study. However, according to the lawsuit, Novo Nordisk knew, or should have known, of the potential side effects long before that study was published. The company had data from pre-clinical trials, premarket clinical trials, post-market surveillance studies, adverse event reports, all of which should have pointed to the conclusion that Ozempic could cause NAION and permanent, incurable vision loss, Symonds alleges. The complaint also points out that Novo Nordisk spent “hundreds of millions of dollars” marketing GLP-1 products like Ozempic, while simultaneously withholding and misrepresenting information that was obtained after FDA approval regarding possible side effects of the drugs. Symonds presents claims for failure to warn, breach of warranty, fraudulent concealment, fraudulent/intentional misrepresentation, negligent misrepresentation, strict product liability misrepresentation, negligent design, strict liability design defect, negligence, and negligent undertaking. He seeks both compensatory and punitive damages. July 2025 Ozempic Gastroparesis Lawsuits While Symonds’ complaint joins a growing number of NAION Ozempic lawsuits, thousands of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits filed over debilitating stomach paralysis injuries are currently consolidated before U.S. District Judge Karen S. Marston in the Eastern District of Pennsylvania. Judge Marston is presiding over coordinated discovery and pretrial proceedings to prepare a small group of cases for early trial dates. However, before scheduling the first bellwether trials, she has tasked the parties with addressing a number of “cross-cutting” issues, including whether claims are preempted by federal law, whether plaintiffs are required to present specific diagnostic testing evidence to substantiate their injuries, and whether there is sufficient general causation evidence linking Ozempic and the gastrointestinal injuries. While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future. To stay up to date on this litigation, sign up to receive Ozempic lawsuit updates sent directly to your inbox. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Blindness, Diabetes Drug, GLP-1, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Vision Loss, Wegovy, Weight Loss Drug Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. More Ozempic, Wegovy and Mounjaro Stories Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators July 15, 2025 Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (Posted: yesterday) Talcum powder injury lawyers have been assigned to oversee settlement negotiations aiming to resolve nearly 100,000 lawsuits alleging Johnson & Johnson talc-based products can cause cancer. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSLawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (07/03/2025)Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025) Strattice Mesh Lawsuit Scheduled for First Federal Bellwether Trial (Posted: 2 days ago) A U.S. federal magistrate judge will meet with parties this Wednesday to discuss preparation for the first Strattice hernia mesh bellwether trial that is scheduled to begin in February. MORE ABOUT: HERNIA MESH LAWSUITCovidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (05/21/2025)Second Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025) Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: 3 days ago) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)
Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (Posted: yesterday) Talcum powder injury lawyers have been assigned to oversee settlement negotiations aiming to resolve nearly 100,000 lawsuits alleging Johnson & Johnson talc-based products can cause cancer. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSLawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (07/03/2025)Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)
Strattice Mesh Lawsuit Scheduled for First Federal Bellwether Trial (Posted: 2 days ago) A U.S. federal magistrate judge will meet with parties this Wednesday to discuss preparation for the first Strattice hernia mesh bellwether trial that is scheduled to begin in February. MORE ABOUT: HERNIA MESH LAWSUITCovidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (05/21/2025)Second Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)
Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (Posted: 3 days ago) Hologic, Inc. faces a BioZorb tissue marker lawsuit filed by two Montana women who say the implants failed to absorb properly into their bodies. MORE ABOUT: BIOZORB LAWSUITLawyers Preparing BioZorb Lawsuit To Go Before Jury on Sept. 8, 2025 (07/23/2025)Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (07/07/2025)BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)